⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for penile squamous cell carcinoma

Every month we try and update this database with for penile squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS)NCT04231981
Penile Cancer
INCMGA0012
18 Years - MedSIR
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsNCT02496208
Bladder Small C...
Bladder Squamou...
Bladder Urothel...
Clear Cell Rena...
Invasive Bladde...
Invasive Bladde...
Invasive Sarcom...
Kidney Medullar...
Malignant Genit...
Malignant Solid...
Penile Carcinom...
Penile Squamous...
Renal Cell Carc...
Renal Pelvis Ur...
Sarcomatoid Ren...
Stage III Bladd...
Stage III Penil...
Stage III Renal...
Stage III Renal...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IV Bladde...
Stage IV Penile...
Stage IV Renal ...
Stage IV Renal ...
Stage IV Ureter...
Stage IV Urethr...
Ureter Urotheli...
Urethral Urothe...
Biopsy
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsNCT02496208
Bladder Small C...
Bladder Squamou...
Bladder Urothel...
Clear Cell Rena...
Invasive Bladde...
Invasive Bladde...
Invasive Sarcom...
Kidney Medullar...
Malignant Genit...
Malignant Solid...
Penile Carcinom...
Penile Squamous...
Renal Cell Carc...
Renal Pelvis Ur...
Sarcomatoid Ren...
Stage III Bladd...
Stage III Penil...
Stage III Renal...
Stage III Renal...
Stage III Renal...
Stage III Urete...
Stage III Ureth...
Stage IV Bladde...
Stage IV Penile...
Stage IV Renal ...
Stage IV Renal ...
Stage IV Ureter...
Stage IV Urethr...
Ureter Urotheli...
Urethral Urothe...
Biopsy
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Trial of Pembrolizumab for Advanced Penile Squamous Cell CarcinomaNCT02837042
Penile Squamous...
Pembrolizumab
18 Years - University of Alabama at Birmingham
Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile CarcinomaNCT03774901
Penile Cancer
Penile Neoplasm...
Penile Squamous...
Avelumab
18 Years - Centre Hospitalier Universitaire de Besancon
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile CancerNCT00066391
Penile Cancer
cisplatin
irinotecan hydr...
neoadjuvant the...
- 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Molecular Characterization of Penile Cancers in Developing CountriesNCT06068998
Penile Squamous...
18 Years - Latin American Cooperative Oncology Group
Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile CarcinomaNCT03774901
Penile Cancer
Penile Neoplasm...
Penile Squamous...
Avelumab
18 Years - Centre Hospitalier Universitaire de Besancon
Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile CarcinomaNCT03774901
Penile Cancer
Penile Neoplasm...
Penile Squamous...
Avelumab
18 Years - Centre Hospitalier Universitaire de Besancon
Oral Rigosertib for Squamous Cell CarcinomaNCT01807546
Head and Neck S...
Anal Squamous C...
Lung Squamous C...
Cervical Squamo...
Esophageal Squa...
Skin Squamous C...
Penile Squamous...
rigosertib
18 Years - Traws Pharma, Inc.
Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNCT02834013
Acinar Cell Car...
Adenoid Cystic ...
Adrenal Cortica...
Adrenal Gland P...
Anal Canal Neur...
Anal Canal Undi...
Angiosarcoma
Apocrine Neopla...
Appendix Mucino...
Bartholin Gland...
Basal Cell Carc...
Bladder Adenoca...
Breast Metaplas...
Cervical Adenoc...
Cholangiocarcin...
Chordoma
Colorectal Squa...
Desmoid Fibroma...
Endometrial Tra...
Endometrioid Ad...
Esophageal Neur...
Esophageal Undi...
Extrahepatic Bi...
Extramammary Pa...
Fallopian Tube ...
Fallopian Tube ...
Fibromyxoid Tum...
Gallbladder Car...
Gastric Neuroen...
Gastric Squamou...
Gastric Undiffe...
Gastrointestina...
Gestational Tro...
Giant Cell Carc...
Human Papilloma...
Intestinal Neur...
Intrahepatic Ch...
Lung Neuroendoc...
Lung Sarcomatoi...
Major Salivary ...
Malignant Odont...
Malignant Perip...
Malignant Solid...
Malignant Testi...
Metastatic Mali...
Metastatic Pitu...
Minimally Invas...
Mixed Mesoderma...
Mucinous Adenoc...
Mucinous Cystad...
Nasal Cavity Ad...
Nasal Cavity Ca...
Nasopharyngeal ...
Nasopharyngeal ...
Nasopharyngeal ...
Oral Cavity Car...
Oropharyngeal U...
Ovarian Adenoca...
Ovarian Germ Ce...
Ovarian Mucinou...
Ovarian Squamou...
Ovarian Transit...
Pancreatic Acin...
Pancreatic Neur...
Paraganglioma
Paranasal Sinus...
Paranasal Sinus...
Parathyroid Gla...
PEComa
Penile Squamous...
Peritoneal Meso...
Placental Chori...
Primary Periton...
Pseudomyxoma Pe...
Rare Disorder
Scrotal Squamou...
Seminal Vesicle...
Seminoma
Serous Cystaden...
Small Intestina...
Small Intestina...
Spindle Cell Ne...
Teratoma With S...
Testicular Non-...
Thyroid Gland C...
Tracheal Carcin...
Transitional Ce...
Ureter Adenocar...
Ureter Squamous...
Urethral Adenoc...
Urethral Squamo...
Vaginal Adenoca...
Vaginal Squamou...
Vulvar Carcinom...
Biospecimen Col...
Computed Tomogr...
Echocardiograph...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS)NCT04231981
Penile Cancer
INCMGA0012
18 Years - MedSIR
Trial of Pembrolizumab for Advanced Penile Squamous Cell CarcinomaNCT02837042
Penile Squamous...
Pembrolizumab
18 Years - University of Alabama at Birmingham
Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)NCT02279576
Penile Squamous...
Pazopanib
Paclitaxel
18 Years - Spanish Oncology Genito-Urinary Group
Isotretinoin Plus Interferon in Treating Patients With Recurrent CancerNCT00002506
Cervical Cancer
Esophageal Canc...
Head and Neck C...
Lung Cancer
Non-melanomatou...
Penile Cancer
recombinant int...
isotretinoin
18 Years - Hoag Memorial Hospital Presbyterian
Isotretinoin Plus Interferon in Treating Patients With Recurrent CancerNCT00002506
Cervical Cancer
Esophageal Canc...
Head and Neck C...
Lung Cancer
Non-melanomatou...
Penile Cancer
recombinant int...
isotretinoin
18 Years - Hoag Memorial Hospital Presbyterian
Molecular Characterization of Penile Cancers in Developing CountriesNCT06068998
Penile Squamous...
18 Years - Latin American Cooperative Oncology Group
Oral Rigosertib for Squamous Cell CarcinomaNCT01807546
Head and Neck S...
Anal Squamous C...
Lung Squamous C...
Cervical Squamo...
Esophageal Squa...
Skin Squamous C...
Penile Squamous...
rigosertib
18 Years - Traws Pharma, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: